In this study, immunohistochemical analysis was performed in 64 specimens, including 32 LMS, 16 uterine leiomyoma and 16 normal myometrial to quantify and localize the expression of EZH2 protein. This evidence concerns the gene EZH2 and uterine corpus leiomyoma.